Search for: "Tom Lamb" Results 541 - 560 of 1,045
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Dec 2011, 11:02 am by Tom Lamb
Three More Lawsuits (Boles, Jellema, and Spano) Set For Trial, And A Special Master Appointed To Conduct Settlement Talks (Posted by Tom Lamb at DrugInjuryWatch.com) There are currently more than 900 Fosamax lawsuits pending against defendant Merck Sharp & Dohme Corp. [read post]
22 Dec 2011, 2:52 pm by Tom Lamb
December 2011: Some Recent Medical Studies About These Bisphosphonate-Related Subtorchanteric Or Atypical Femoral Fractures (Posted by Tom Lamb at DrugInjuryWatch.com) Here are some recent reports about medical studies concerning the association, or link, between bisphosphonate drugs such as Fosamax and Boniva that are used to treat osteoporosis and the risk of a rare but serious type of thigh bone fracture known as an "atypical femur fracture. [read post]
16 Dec 2011, 8:51 am by admin
On one of the last occasions I saw him, my wife and I came to drop some food –- lamb tagine -– to sustain a family with more on its mind than cooking. [read post]
15 Dec 2011, 11:15 am by Tom Lamb
Adverse Event Reports For This New Blood Thinner Drug May Exceed Pre-Approval Clinical Trial Observations (Posted by Tom Lamb at DrugInjuryWatch.com) In early December 2011 the FDA announced it is evaluating reports of bleeding in patients taking Pradaxa (dabigatran etexilate mesylate) that have been submitted to the agency's Adverse Events Reporting System (AERS) database to determine whether serious side effects are occurring at a higher rate than… [read post]
7 Dec 2011, 5:16 am by Tom Lamb
J&J Birth Control Patch Ortho Evra Safety Review Will Focus On Blood Clot Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE:  Transcript for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee  (PDF - 685KB) … [read post]
6 Dec 2011, 12:35 pm by Andrew Ramonas
Tom Goldstein, publisher of SCOTUSblog and a founding partner of Goldstein & Russell, predicted during his testimony that at least 50 million people would watch the Court’s review of the health care law if it were televised. [read post]
6 Dec 2011, 8:55 am by Tom Lamb
Expert Reports From YAZ / Yasmin Lawsuits Will Not Be Considered Because Submitted After Deadline Set By FDA (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE:  "Bayer Birth Control Pill Benefits Outweigh Risks, Panel Says" (12/8/11, Bloomberg) (12/12/11) _____________________________________________________________________ In October 2011 the FDA released its new drug-safety study report,… [read post]
1 Dec 2011, 2:02 pm by Tom Lamb
Coincidence, But Ironic, Given Several Recent Medical Studies Which Suggest Drospirenone (DRSP) Causes Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) On November 29, 2011 Watson Pharmaceuticals issued this press release, "Watson's Generic Yaz(R) Receives FDA Approval", which begins as follows: Watson Pharmaceuticals, Inc. [read post]
23 Nov 2011, 1:13 pm by Tom Lamb
Analysis Of PALLAS Study Data Shows Two-Times Increased Risk Of Death, Stroke, And Heart Attack (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE:  FDA Drug Safety Communication: Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events Safety Announcement [12-19-2011] The U.S. [read post]
17 Nov 2011, 12:18 pm by Tom Lamb
Level Of Concern About These Incretin Therapies For Diabetes Was Raised By Gastroenterology Medical Journal Article (Posted by Tom Lamb at DrugInjuryWatch.com) In September 2011, at the 47th European Association for the Study of Diabetes (EASD) Annual Meeting, Diabetes Medical Congress, in Lisbon, Portugal, there was a debate about whether there is an increased risk of pancreatitis, pancreatic cancer, and thyroid cancer for patients who use Januvia (sitagliptin) or Byetta… [read post]
16 Nov 2011, 6:36 am by Medicare Set Aside Services
Tom Blackwell out at Gould and Lamb Comment: Tom is now listed as an independent sales professional on his linked-in page. [read post]
11 Nov 2011, 2:27 pm by Tom Lamb
Researchers Find Drospirenone (DRSP) Containing Birth Control Pills Increased Risk Of Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com) New research published online in October 2011 by the BMJ medical journal and in November 2011 by the Canadian Medical Association Journal (CMAJ) indicates that women who use oral contraceptives (OCs) containing drospirenone (DRSP) have an increased risk of venous thromboembolism (VTE) such as… [read post]
7 Nov 2011, 7:04 am by Carolyn Elefant
As bloggers Tom Kane and Patrick Lamb discuss, large firm realization rates have dropped to an all time low, with big firms collecting just 85.4 percent of revenues billed. [read post]
2 Nov 2011, 1:47 pm by Tom Lamb
(Posted by Tom Lamb at DrugInjuryWatch.com) On October 27, 2011 the FDA released its new drug-safety study report, "Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints", which included the Ortho Evra birth control skin patch (norelgestromin/ethinyl estradiol transdermal patch) -- referred to as "NGMN" in this 2011 FDA study report. [read post]
31 Oct 2011, 1:39 pm by Tom Lamb
Safety Study Findings About Drospirenone (DRSP) Birth Control Pills Will Be On The Agenda For FDA Advisory Committees At Joint Meeting In December 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) On October 27, 2011 the FDA released its new drug-safety study report, "Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints", which included the popular birth control pills YAZ, Yasmin, and Ocella. [read post]
28 Oct 2011, 6:16 pm by Tom Lamb
(Posted by Tom Lamb at DrugInjuryWatch.com) On October 27, 2011 the FDA released its new drug-safety study report, "Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints", which included the NuvaRing (etonogestrel / estradiol vaginal ring) -- referred to as "ETON" in this 2011 FDA study report. [read post]
20 Oct 2011, 5:36 am by Tom Lamb
Here Is Why Aetna Wants To Know Whether You Have Filed A Gallbladder Or A Blood Clot Lawsuit Against Bayer (Posted by Tom Lamb at DrugInjuryWatch.com) We have learned that women who took the birth control pills YAZ, Yasmin, or Ocella while they had medical insurance from Aetna are receiving letters asking questions such as: Did you suffer any cardiovascular - or gallbladder - related injury or injuries during or after [the period when you used Yaz, Yasmin, or Ocella]? [read post]
14 Oct 2011, 9:59 pm by JD Hull
, Lance Godard CBA Practice Link, Canadian Bar Association In Search of Perfect Client Service, Patrick Lamb Minor Wisdom, Ray Ward, New Orleans the (new) legal writer, Ray Ward Simple Justice, Scott H. [read post]
13 Oct 2011, 6:23 am by Tom Lamb
ISMP Quarterwatch 2010 4th Quarter: Hemorrhages And Thromboembolic Events Have Been Reported To FDA (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE:  "Boehringer says about 260 deaths related to Pradaxa" (11/12/11, Reuters) FRANKFURT Nov 12 (Reuters) - Boehringer Ingelheim said that 260 cases of fatal bleeding have been linked to its new stroke prevention pill Pradaxa so far,… [read post]
6 Oct 2011, 1:55 pm by Tom Lamb
Medical Clues Include Prior Symptoms, Location Of Thigh Bone Break, And Specific Radiology Findings (Posted by Tom Lamb at DrugInjuryWatch.com) For this medical primer about femur fractures which might be associated with Fosamax as well as the several other bisphosphonate osteoporosis medications available in the U.S. we will start with some basic anatomy taken from a document titled "Femur Shaft Fractures (Broken Thighbone)", published by the American Academy… [read post]